Liyun Zheng, Shiji Fang, Aifang Chen, Weiqian Chen, Enqi Qiao, Minjiang Chen, . . . Jiansong Ji. (2022). Piperlongumine synergistically enhances the antitumour activity of sorafenib by mediating ROS-AMPK activation and targeting CPSF7 in liver cancer. Elsevier.
Chicago Style (17th ed.) CitationLiyun Zheng, et al. Piperlongumine Synergistically Enhances the Antitumour Activity of Sorafenib by Mediating ROS-AMPK Activation and Targeting CPSF7 in Liver Cancer. Elsevier, 2022.
MLA (9th ed.) CitationLiyun Zheng, et al. Piperlongumine Synergistically Enhances the Antitumour Activity of Sorafenib by Mediating ROS-AMPK Activation and Targeting CPSF7 in Liver Cancer. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.